⌘K
Loading ticker…
Coya Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Coya Therapeutics, Inc. Common Stock (COYA) has a 3-month relative strength percentile of 82 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.8%, relative volume 1.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 82, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
COYA is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $868K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COYA Jan avg: -11.07% median: -15.01% win: 25% σ: 12.37% n: 4 2022-12-30 → 2026-05-29 | COYA Feb avg: 17.89% median: 11.56% win: 75% σ: 24.45% n: 4 2022-12-30 → 2026-05-29 | COYA Mar avg: -5.41% median: -5.70% win: 25% σ: 12.85% n: 4 2022-12-30 → 2026-05-29 | COYA Apr avg: 5.44% median: 4.61% win: 75% σ: 12.52% n: 4 2022-12-30 → 2026-05-29 | COYA May avg: -7.06% median: -11.53% win: 25% σ: 14.87% n: 4 2022-12-30 → 2026-05-29 | COYA Jun avg: -7.18% median: -8.95% win: 33% σ: 14.26% n: 3 2022-12-30 → 2026-05-29 (current) | COYA Jul avg: 4.82% median: 3.48% win: 67% σ: 7.79% n: 3 2022-12-30 → 2026-05-29 | COYA Aug avg: -4.38% median: -11.31% win: 33% σ: 12.68% n: 3 2022-12-30 → 2026-05-29 | COYA Sep avg: 0.88% median: 6.97% win: 67% σ: 12.15% n: 3 2022-12-30 → 2026-05-29 | COYA Oct avg: 15.30% median: 12.09% win: 100% σ: 6.63% n: 3 2022-12-30 → 2026-05-29 | COYA Nov avg: 2.04% median: 3.01% win: 67% σ: 11.40% n: 3 2022-12-30 → 2026-05-29 | COYA Dec avg: 4.92% median: -3.61% win: 50% σ: 23.84% n: 4 2022-12-30 → 2026-05-29 |